13 May 2022
OBERON Annual Meeting 2022
09 May 2022
> Dissemination > Events > News & Press Releases
OBERON Annual Meeting in Barcelona The OBERON project held its 3rd annual meeting the 5th and 6th of may in Barcelona, where partner and host Barcelona Institute for Global Health (ISGlobal) is based. The meeting was chaired by coordinator Karine Audouze and Robert Barouki from Inserm. Both online and in person, this hybrid meeting gathered around 60 to 70 persons amongst partners Read the full article…
Enquête – Nos chercheurs répondent à vos questions sur les perturbateurs endocriniens !
25 Avril 2022
> Dissemination > Events > News & Press Releases
Pour vous, qu'est-ce qu'un perturbateur endocrinien? Avez-vous déjà entendu parlé des perturbateurs endocriniens ? Que comprenez-vous exactement quand on parle des perturbateurs endocriniens ? Ce sont des questions que l’on pose dans ce sondage (disponible ici). L’objectif de cette grande enquête est de mieux visualiser la perception du grand public et d'identifier les points encore confus quand Read the full article…
EURION New Policy Brief!
5 March 2022
> Dissemination > News & Press Releases
Towards safer chemicals recommendations for reliable test methods to identify endocrine disruptors (EDs) A new policy brief published outlines recommendations for test methods to identify endocrine disruptors (ED). Existing regulations require pesticides and antimicrobial agents to undergo an ED assessment, but legislation will soon require thousands more industrial chemicals to fulfil the same requirements. Current Read the full article…
Young OBERON Challenge
13 September 2021
> Dissemination > News & Press Releases
Young OBERON's first videos ! Charline Warembourg, PhD at INSERM, working on OBERON project, shot this video for Tik Tok, Instagram and Twitter, presenting herself and her carrier in a playful way. A second video will come out this week. A couple videos will be published on social media each month to touch a young Read the full article…
New Scientific article on Artificial Intelligence in the context of OBERON
26 April 2021
> Dissemination > News & Press Releases > Publications
Identification of non-validated endocrine disrupting chemical characterization methods by screening of the literature using artificial intelligence and by database exploration A new article by Elias Zgheib – postdoc working on the project – has been published in Environment International on Identifiation of non-validated EDCs characterization methods by screening of the literature using AI and by database Read the full article…
OBERON Newsletter
15 March 2021
> Dissemination > News & Press Releases
OBERON first Newsletter OBERON March 2021 Newsletter, please subscribe by leaving us a message in the Contact Us section. March 2021 Newsletter
Mention of scientists from the Czech Institute of Biophysics participation in OBERON
22 January 2021
> Dissemination > Documents > News & Press Releases > Publications
Mention of scientists from the Czech Institute of Biophysics participation in OBERON A short description of OBERON and participation of the Institute of Biophysics CAS in the project has been published in the Czech popular science magazine Vesmír (2020; vol. 99, issue 10, p. 600), in Czech. This one-page summary provides a short description of Read the full article…
Possible connection between exposure to endocrine disruptors and COVID-19 severity
November 23, 2020
> News & Press Releases > Publications
NEW ARTICLES : New press articles have been posted on the link between ED’s exposure and COVID-19 severity Inserm press article “Rôle possible de l’exposition aux perturbateurs endocriniens dans la sévérité de la Covid-19” Pubmed article “New research examines suspected links between EDCs exposure and COVID-19” Inserm article (FR) Pubmed article (EN)
OBERON press release
14 April 2019
> News & Press Releases
Coordinated by Inserm, the European project OBERON aims to develop panels of tests that will – eventually – make it possible to determine with more accuracy and certitude how compounds suspected of being endocrine disruptors might induce metabolic disorders and, ultimately, to identify these compounds.
Download presentation leaflet